Oppenheimer Asset Management Inc. Decreases Position in Credicorp Ltd. (NYSE:BAP)

Oppenheimer Asset Management Inc. lowered its stake in Credicorp Ltd. (NYSE:BAPFree Report) by 5.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 12,199 shares of the bank’s stock after selling 664 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Credicorp were worth $1,561,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of the stock. O Shaughnessy Asset Management LLC lifted its holdings in Credicorp by 3.9% during the 2nd quarter. O Shaughnessy Asset Management LLC now owns 1,764 shares of the bank’s stock worth $260,000 after buying an additional 67 shares during the last quarter. Pathstone Family Office LLC lifted its holdings in Credicorp by 2.8% during the 3rd quarter. Pathstone Family Office LLC now owns 2,682 shares of the bank’s stock worth $329,000 after buying an additional 72 shares during the last quarter. Crossmark Global Holdings Inc. lifted its holdings in Credicorp by 3.1% during the 2nd quarter. Crossmark Global Holdings Inc. now owns 3,031 shares of the bank’s stock worth $479,000 after buying an additional 92 shares during the last quarter. Signaturefd LLC lifted its holdings in Credicorp by 22.4% during the 2nd quarter. Signaturefd LLC now owns 520 shares of the bank’s stock worth $77,000 after buying an additional 95 shares during the last quarter. Finally, Parallel Advisors LLC lifted its holdings in Credicorp by 41.4% during the 2nd quarter. Parallel Advisors LLC now owns 393 shares of the bank’s stock worth $58,000 after buying an additional 115 shares during the last quarter. Institutional investors and hedge funds own 70.05% of the company’s stock.

Credicorp Stock Up 2.1 %

Shares of BAP stock opened at $153.38 on Wednesday. Credicorp Ltd. has a 1 year low of $116.42 and a 1 year high of $160.15. The stock has a market cap of $12.20 billion, a PE ratio of 9.95, a price-to-earnings-growth ratio of 0.65 and a beta of 1.10. The business’s fifty day moving average is $144.42 and its 200-day moving average is $138.27. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.00 and a current ratio of 1.00.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on BAP shares. UBS Group reduced their target price on Credicorp from $192.00 to $190.00 and set a “buy” rating on the stock in a report on Monday. Jefferies Financial Group assumed coverage on Credicorp in a report on Monday, October 16th. They issued a “buy” rating and a $161.20 price target on the stock. Finally, JPMorgan Chase & Co. raised Credicorp from a “neutral” rating to an “overweight” rating and raised their price target for the stock from $162.00 to $190.00 in a report on Friday, December 15th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $180.40.

Check Out Our Latest Stock Analysis on BAP

About Credicorp

(Free Report)

Credicorp Ltd. provides various financial, insurance, and health services and products primarily in Peru and internationally. Its Universal Banking segment includes granting various credits and financial instruments to individuals and legal entities; and various deposits and checking accounts. The Insurance and Pensions segment includes the issuance of insurance policies to cover losses in commercial property, transport, marine vessels, automobiles, life, health, and pensions; management services for private pension funds.

Recommended Stories

Institutional Ownership by Quarter for Credicorp (NYSE:BAP)

Receive News & Ratings for Credicorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Credicorp and related companies with MarketBeat.com's FREE daily email newsletter.